Skip to main content
OpenTrials
Completed

NCT Number: NCT03227068

Parent Educational Discharge Support Strategies

After the initial hospitalization, parents of children newly diagnosed with cancer assume responsibility for assessing and managing their care; however, parents are often overwhelmed with information received throughout the hospitalization and are apprehensive about caring for their child at home. Parents want concise, focused information on how to care for their child after the hospital discharge. Two parent education discharge support strategies (PEDSS) were created to use at hospital discharge. PEDSS consists of a symptom management intervention and a support for the caregiver intervention. A cluster randomized control trial will assess the effectiveness and feasibility of the two different interventions.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

King Faisal Specialist Hospital and Research Centre-Riyadh, Riyadh, Saudi Arabia

Loading trial locations.

About this study

Providing education to parents of children newly diagnosed with cancer is a primary component of nursing practice, but best practices regarding delivery of information are not known. Parents often report confusion and worry with the complexity and large volume of information received during the initial hospitalization that leads to concerns in caring for their child after discharge. In addition, the amount and content of education is not standardized across institutions. This results in considerable variability in educational practices, including symptom education. During a recent qualitative study, parents described helpful discharge education strategies as having written materials, keeping information concise, and receiving anticipatory guidance so they knew what to expect. These preferences were succinctly summarized by a mother of a child newly diagnosed with leukemia who stated "…it would be nice to have one sheet of paper that just said 'these are the signs that you're looking for at home'." The purpose of this research study is to implement and evaluate parent educational discharge support strategies (PEDSS) for parents of children newly diagnosed with cancer. Findings from this study will provide a framework for nurses to deliver concise and consistent information to parents of children newly diagnosed with cancer, and will assist parents with their child after hospital discharge.

The goal of this study is to determine the effectiveness and feasibility of two parent education discharge support strategies (PEDSS - symptom management vs. PEDSS - support for the caregiver) for parents of children newly diagnosed with cancer. Specific aims of the study include:

Specific Aim 1: Explore the effects of parent education discharge support strategies on childhood cancer symptoms (fever, pain, fatigue, nausea, appetite changes, and sleep problems) and parents' perception of their ability to care for their child with a new cancer diagnosis during the first two months following the initial hospital discharge.

Specific Aim 2: Determine whether implementation of parent education discharge support strategies decreases unplanned utilization of healthcare services (unscheduled clinic visits, emergency room visits, unplanned hospitalizations), and preventable toxicity (malnutrition, sepsis) among children with cancer during the first two months following the initial hospitalization.

Specific Aim 3: Examine the feasibility and fidelity of implementing the PEDSS at the initial hospital discharge among parents of newly diagnosed children with cancer for use through the first two months following hospital discharge at participating Magnet institutions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A parent (referred to as "parent" but includes a parent or legal guardian) of a patient 3 to 17 years of age who is newly diagnosed with any type of malignant disease on an inpatient oncology unit
  • Must speak English, Spanish, or Arabic
  • Child will be or is receiving chemotherapy and/or radiation therapy

Exclusion criteria

  • A parent of a child diagnosed with histiocytosis or any hematological disease considered non-malignant
  • A parent whose child received the initial cancer diagnosis and initial cancer treatment while hospitalized on a non-oncology unit (i.e., surgical ward)
  • A parent of a child who is experienced a relapse of a malignant disease
  • A parent who is the primary caregiver of the child with cancer and is illiterate

Treatment and study plan

PEDSS - symptom management

Other

All subjects will receive education regarding their specific disease and treatment in accordance with current practices. Cancer care providers describe detailed side effects of treatment to parents during the treatment consent process. In addition, all parents will receive standard discharge education before hospital discharge, which includes a list of home medications and information regarding whom to call for emergencies. The PEDSS - symptom management will be delivered prior to the initial hospital discharge. The nurse will review the symptom management worksheet verbally with the parent, then distribute the written worksheet to the parent.

PEDSS - support for the caregiver

Other

All subjects will receive education regarding their specific disease and treatment in accordance with current practices. Cancer care providers describe detailed side effects of treatment to parents during the treatment consent process. In addition, all parents will receive standard discharge education before hospital discharge, which includes a list of home medications and information regarding whom to call for emergencies. The PEDSS - support for the caregiver will be delivered prior to the initial hospital discharge. The nurse will review the worksheet verbally with the parent, then distribute the written worksheet to the parent.

Primary outcomes

  1. Change from baseline pain severity to two months

    Time frame: At baseline and monthly for two additional months

    Wong-Baker Faces Scale

  2. Change from baseline fatigue severity to two months

    Time frame: At baseline and monthly for two additional months

    Categorized as none to mild or moderate to severe from the Adolescent Fatigue Scale for adolescents 13-17 years of age, the Childhood Fatigue Scale for children 7-12 years of age, or the Parent Fatigue Scale to obtain proxy responses from parents of children < 7 years of age

  3. Change from baseline nausea severity to two months

    Time frame: At baseline and monthly for two additional months

    Visual Analogue Scale in the form of a thermometer that rates the severity of nausea from 0-100

  4. Change from baseline appetite changes to two months

    Time frame: At baseline and monthly for two additional months

    Simplified Nutritional Appetite Questionnaire, 4-item asking about child's appetite and rated on a 5-point Likert Scale

  5. Change from baseline sleep disturbances to two months

    Time frame: At baseline and monthly for two additional months

    The Sleep Wake Scale

  6. Change from baseline pain behavior to two months

    Time frame: At baseline and monthly for two additional months

    PROMIS® Pediatric - Pain Behavior Short Form

Secondary outcomes

  1. Change of baseline parents' perception of their ability to care for their child with a new cancer diagnosis to two months

    Time frame: At baseline and monthly for two additional months

    Seven items asking the parent to rate perceptions of the care of their child's symptoms on a 5-point Likert scale

  2. Unplanned utilization of healthcare services

    Time frame: At one and two months from start of study

    Combined frequency of the number of unscheduled clinic visits, emergency room visits, and unplanned hospitalizations

  3. Change in baseline nutritional status to two months

    Time frame: At baseline and monthly for two additional months

    Body mass index

  4. Sepsis

    Time frame: At one and two months from start of study

    Frequency of septic events over the past month

  5. PEDSS intervention feasibility

    Time frame: At baseline

    Nurse documentation of completion of PEDSS discussion and distribution of PEDSS worksheet

  6. PEDSS intervention satisfaction

    Time frame: At two months after intervention delivery

    Descriptive items asking about timing of intervention and frequency of intervention use then 6 items scored on a 5-point Likert scale asking about ease of use and satisfaction.

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago
  • Children's Health System of Texas Children's Medical Center
  • Cohen Children's Medical Center
  • King Faisal Specialist Hospital & Research Center
  • Levine Children's Hospital
  • Maine Children's Cancer Program at Maine Medical Center
  • Medical University of South Carolina Shawn Jenkins Children's Hospital
  • Nationwide Children's Hospital
  • Nicklaus Children's Hospital
  • Northwestern Medicine Central DuPage Hospital
  • St. Jude Children's Research Hospital
  • St. Louis Children's Hospital
  • St. Peter's University Hospital
  • University of Wisconsin Health American Children's Hospital
  • West Virginia Univeristy Medicine

Registry information

Official study title

Nurse-Led Parent Educational Discharge Support Strategies (PEDSS) for Children Newly Diagnosed With Cancer

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Jul 24, 2017
Registry last updated
Jun 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.